Carisma Therapeutics, Inc.
CARM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$60,477 | -$86,879 | -$61,226 | -$40,784 |
| Dep. & Amort. | $3,354 | $2,837 | $6,090 | $682 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,649 | $2,316 | $0 | $479 |
| Change in WC | -$11,952 | -$5,436 | $45,196 | $1,461 |
| Other Non-Cash | $5,509 | $5,985 | $2,374 | $834 |
| Operating Cash Flow | -$59,917 | -$81,177 | -$7,566 | -$37,328 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$123 | -$1,132 | -$4,660 | -$1,871 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$34,460 | -$90,900 | $0 |
| Inv. Sales/Matur. | $0 | $108,000 | $63,000 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$123 | $72,408 | -$32,560 | -$1,871 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,429 | -$1,301 | -$865 | $0 |
| Stock Issued | $2,392 | $31,237 | $35,106 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$619 | $32,244 | $1,528 | $15,962 |
| Financing Cash Flow | $344 | $62,180 | $35,769 | $15,962 |
| Forex Effect | $0 | $0 | -$134,085 | $0 |
| Net Chg. in Cash | -$59,696 | $53,411 | -$138,442 | -$23,237 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $77,605 | $24,194 | $162,636 | $51,788 |
| End Cash | $17,909 | $77,605 | $24,194 | $28,551 |
| Free Cash Flow | -$60,040 | -$82,309 | -$12,226 | -$39,199 |